Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia
- PMID: 25683629
- PMCID: PMC4376621
- DOI: 10.1002/pbc.25447
Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia
Abstract
Carbon monoxide (CO) production from heme catabolism is increased with hemolysis. A portable end-tidal CO (ETCO) monitor was used to analyze breath samples in 16 children with sickle cell anemia (SCA, 5-14 years). Median (range) ETCO for SCA was 4.35 ppm (1.8-9.7) versus 0.80 ppm (0.2-2.3) for controls (P < 0.001). ETCOc >2.1 ppm provided sensitivity and specificity of 93.8% (69.8-99.8%) for detecting SCA. ETCO correlated with reticulocytosis (P = 0.015) and bilirubin (P = 0.009), and was 32% lower in children receiving hydroxyurea (P = 0.09). Point-of-care ETCO analysis may prove useful for non-invasive monitoring of hemolysis and as a screening test for SCA.
Keywords: hemoglobinopathies; red blood cell disorders; sickle cell anemia.
© 2015 Wiley Periodicals, Inc.
Conflict of interest statement
Figures


Similar articles
-
Exhaled carbon monoxide levels in children with sickle cell disease.Eur J Pediatr. 2005 Mar;164(3):162-5. doi: 10.1007/s00431-004-1605-8. Epub 2004 Dec 15. Eur J Pediatr. 2005. PMID: 15599764
-
Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy.Pediatr Hematol Oncol. 2010 Mar;27(2):112-21. doi: 10.3109/08880010903536227. Pediatr Hematol Oncol. 2010. PMID: 20201692
-
Validation of the Natus CO-Stat End Tidal Breath Analyzer in children and adults.J Clin Monit Comput. 1999 Dec;15(7-8):421-7. doi: 10.1023/a:1009982011226. J Clin Monit Comput. 1999. PMID: 12578038 Clinical Trial.
-
End-tidal carbon monoxide and hemolysis.J Perinatol. 2014 Aug;34(8):577-81. doi: 10.1038/jp.2014.66. Epub 2014 Apr 17. J Perinatol. 2014. PMID: 24743136 Review.
-
Neonatal/perinatal diagnosis of hemolysis using ETCOc.Semin Fetal Neonatal Med. 2025 Mar;30(1):101547. doi: 10.1016/j.siny.2024.101547. Epub 2024 Oct 22. Semin Fetal Neonatal Med. 2025. PMID: 39455373 Review.
Cited by
-
Hemolysis during and after 21 days of head-down-tilt bed rest.Physiol Rep. 2017 Dec;5(24):e13469. doi: 10.14814/phy2.13469. Physiol Rep. 2017. PMID: 29263114 Free PMC article. Clinical Trial.
-
Impact of Hydroxyurea on Clinical and Biological Parameters of Sickle Cell Anemia in Children in Abidjan.Mediterr J Hematol Infect Dis. 2024 Mar 1;16(1):e2024026. doi: 10.4084/MJHID.2024.026. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38468842 Free PMC article. No abstract available.
-
White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa.J Trop Dis Public Health. 2018;6(2):260. doi: 10.4172/2329-891X.1000260. Epub 2018 Jul 10. J Trop Dis Public Health. 2018. PMID: 30505949 Free PMC article.
-
Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future Research.Int J Environ Res Public Health. 2016 Nov 12;13(11):1131. doi: 10.3390/ijerph13111131. Int J Environ Res Public Health. 2016. PMID: 27845754 Free PMC article. Review.
-
Electronic Noses for Well-Being: Breath Analysis and Energy Expenditure.Sensors (Basel). 2016 Jun 23;16(7):947. doi: 10.3390/s16070947. Sensors (Basel). 2016. PMID: 27347946 Free PMC article. Review.
References
-
- Owens EO. Endogenous carbon monoxide production in disease. Clin Biochem. 2010;43:1183–1188. - PubMed
-
- Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010;50:323–354. - PubMed
-
- James EB, Vreman HJ, Wong RJ, Stevenson DK, Vichinsky E, Schumacher L, Hall JY, Simon J, Golden DW, Harmatz P. Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy. Pediatr Hematol Oncol. 2010;27:112–121. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical